Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q3 Earnings

Biopharma company Corcept Therapeutics (NASDAQ:CORT) fell short of the markets revenue expectations in Q3 CY2025, but sales ...

Fund manager who predicted Great Recession sparks fiery Palantir CEO rant

The hedge fund legend who called the 2008 US housing crisis and is the famed investor behind the “Big Short” is back in the ...